Ensysce Biosciences
ENSC
ENSC
12 hedge funds and large institutions have $581K invested in Ensysce Biosciences in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
12
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$236K | |
| 2 | +$204K | |
| 3 | +$27K | |
| 4 |
Renaissance Technologies
New York
|
+$5.38K |
| 5 |
Cerity Partners
New York
|
+$5.14K |
Top Sellers
| 1 | -$15.1K | |
| 2 | -$6.7K | |
| 3 | -$6K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$432 |
| 5 |
MSG
Main Street Group
Glen Allen,
Virginia
|
-$185 |